Furin: A Potential Therapeutic Target for COVID-19
暂无分享,去创建一个
Lixia Chen | Canrong Wu | Yang Liu | Yueying Yang | Peng Zhang | Yali Wang | Qi-qi Wang | Yang Xu | Ming-xue Li | Meng-zhu Zheng | Hua Li | Qingzhe Zhang | Xiaoxia Gu | Yirong Zhou | Kaiyin Yang | Yonghui Zhang
[1] K. Yuen,et al. Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2 , 2020, Cell.
[2] Alice C Hughes,et al. A novel bat coronavirus reveals natural insertions at the S1/S2 cleavage site of the Spike protein and a possible recombinant origin of HCoV-19 , 2020, bioRxiv.
[3] G. Herrler,et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.
[4] Lixia Chen,et al. Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods , 2020, Acta Pharmaceutica Sinica B.
[5] Andrea Marzi,et al. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses , 2020, Nature Microbiology.
[6] Young-Jun Park,et al. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein , 2020, Cell.
[7] B. Canard,et al. The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade , 2020, Antiviral Research.
[8] Yuquan Wei,et al. Structural Analysis of Rabies Virus Glycoprotein Reveals pH-Dependent Conformational Changes and Interactions with a Neutralizing Antibody. , 2020, Cell host & microbe.
[9] M. Letko,et al. Functional assessment of cell entry and receptor usage for lineage B β-coronaviruses, including 2019-nCoV , 2020, bioRxiv.
[10] Ping Chen,et al. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission , 2020, Science China Life Sciences.
[11] A. Walls,et al. Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion , 2019, Cell.
[12] W. Kamitani,et al. Middle East Respiratory Syndrome Coronavirus Spike Protein Is Not Activated Directly by Cellular Furin during Viral Entry into Target Cells , 2018, Journal of Virology.
[13] Kornelia Hardes,et al. X-ray Structures of the Proprotein Convertase Furin Bound with Substrate Analogue Inhibitors Reveal Substrate Specificity Determinants beyond the S4 Pocket. , 2018, Biochemistry.
[14] M. Than,et al. Structural Studies Revealed Active Site Distortions of Human Furin by a Small Molecule Inhibitor. , 2017, ACS chemical biology.
[15] Yi Shi,et al. Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains , 2017, Nature Communications.
[16] S. Perlman,et al. Proteolytic processing of Middle East respiratory syndrome coronavirus spikes expands virus tropism , 2016, Proceedings of the National Academy of Sciences.
[17] R. Huber,et al. Structure of the unliganded form of the proprotein convertase furin suggests activation by a substrate-induced mechanism , 2016, Proceedings of the National Academy of Sciences.
[18] Barney S. Graham,et al. Pre-fusion structure of a human coronavirus spike protein , 2016, Nature.
[19] G. Gao,et al. Bat-to-human: spike features determining ‘host jump’ of coronaviruses SARS-CoV, MERS-CoV, and beyond , 2015, Trends in Microbiology.
[20] Yanchen Zhou,et al. Protease inhibitors targeting coronavirus and filovirus entry , 2015, Antiviral Research.
[21] Gary R. Whittaker,et al. Host cell proteases: Critical determinants of coronavirus tropism and pathogenesis , 2014, Virus Research.
[22] F. Tay,et al. Characterization of cellular furin content as a potential factor determining the susceptibility of cultured human and animal cells to coronavirus infectious bronchitis virus infection , 2012, Virology.
[23] Ryan G. Coleman,et al. ZINC: A Free Tool to Discover Chemistry for Biology , 2012, J. Chem. Inf. Model..
[24] Chawaree Chaipan,et al. Different host cell proteases activate the SARS-coronavirus spike-protein for cell–cell and virus–cell fusion , 2011, Virology.
[25] Christian Drosten,et al. Evidence that TMPRSS2 Activates the Severe Acute Respiratory Syndrome Coronavirus Spike Protein for Membrane Fusion and Reduces Viral Control by the Humoral Immune Response , 2011, Journal of Virology.
[26] R. Bruzzone,et al. Cleavage of the SARS Coronavirus Spike Glycoprotein by Airway Proteases Enhances Virus Entry into Human Bronchial Epithelial Cells In Vitro , 2009, PloS one.
[27] D. Liu,et al. Proteolytic Activation of the Spike Protein at a Novel RRRR/S Motif Is Implicated in Furin-Dependent Entry, Syncytium Formation, and Infectivity of Coronavirus Infectious Bronchitis Virus in Cultured Cells , 2009, Journal of Virology.
[28] G. Whittaker,et al. Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites , 2009, Proceedings of the National Academy of Sciences.
[29] G. Thomas,et al. Identification of a pH Sensor in the Furin Propeptide That Regulates Enzyme Activation* , 2006, Journal of Biological Chemistry.
[30] S. Diamond,et al. Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[31] B. Bosch,et al. The Coronavirus Spike Protein Is a Class I Virus Fusion Protein: Structural and Functional Characterization of the Fusion Core Complex , 2003, Journal of Virology.
[32] R. Huber,et al. The crystal structure of the proprotein processing proteinase furin explains its stringent specificity , 2003, Nature Structural Biology.
[33] Y. Martin,et al. A general and fast scoring function for protein-ligand interactions: a simplified potential approach. , 1999, Journal of medicinal chemistry.
[34] Ruben Abagyan,et al. ICM—A new method for protein modeling and design: Applications to docking and structure prediction from the distorted native conformation , 1994, J. Comput. Chem..
[35] Guangyou Duan,et al. A furin cleavage site was discovered in the S protein of the 2019 novel coronavirus , 2020 .
[36] I. Lindberg,et al. Design, Synthesis, and Characterization of Macrocyclic Inhibitors of the Proprotein Convertase Furin , 2019, ChemMedChem.
[37] Robert Huber,et al. The crystal structure of the proprotein processing proteinase furin explains its stringent specificity , 2003, Nature Structural Biology.